Details for Patent: 7,538,108
✉ Email this page to a colleague
Which drugs does patent 7,538,108 protect, and when does it expire?
Patent 7,538,108 protects TAVALISSE and is included in one NDA.
This patent has thirty-eight patent family members in twenty-nine countries.
Summary for Patent: 7,538,108
Title: | Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
Abstract: | The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds of structural formula shown below, compositions comprising these compounds, intermediates and methods for synthesizing these compounds, and methods of using these compounds in a variety of applications including treatment of autoimmune diseases. ##STR00001## |
Inventor(s): | Singh; Rajinder (Belmont, CA), Masuda; Esteban (Menlo Park, CA), Bhamidipati; Somasekhar (Foster City, CA), Sun; Thomas (Palo Alto, CA), Stella; Valentino J. (Lawrence, KS) |
Assignee: | Rigel Pharmaceuticals, Inc. (South San Francisco, CA) |
Application Number: | 11/453,731 |
Patent Claim Types: see list of patent claims | Use; Compound; |
Drugs Protected by US Patent 7,538,108
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-001 | Apr 17, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT | ⤷ Try a Trial | |||
Rigel Pharms Inc | TAVALISSE | fostamatinib disodium | TABLET;ORAL | 209299-002 | Apr 17, 2018 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) WHO HAVE HAD AN INSUFFICIENT RESPONSE TO A PREVIOUS TREATMENT | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,538,108
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | E451381 | ⤷ Try a Trial | |||
Australia | 2006206458 | ⤷ Try a Trial | |||
Brazil | PI0606318 | ⤷ Try a Trial | |||
Canada | 2591948 | ⤷ Try a Trial | |||
China | 101115761 | ⤷ Try a Trial | |||
Cyprus | 1109888 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |